Bloomberg Intelligence cover image

Kimberly-Clark to Buy Tylenol Maker Kenvue for $40 Billion

Bloomberg Intelligence

00:00

Tylenol Legal Risks and Regulatory Concerns

Paul asks about Tylenol's recent legal troubles and Diana assesses lawsuit exposure and potential regulatory hurdles.

Play episode from 04:07
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app